类风湿关节炎的抗肿瘤坏死因子-α治疗 - Suppr

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.

作者信息

Feldmann M, Elliott M J, Woody J N, Maini R N

机构信息

Mathilda and Terence Kennedy Institute of Rheumatology, London, United Kingdom.

出版信息

Adv Immunol. 1997;64:283-350. doi: 10.1016/s0065-2776(08)60891-3.

DOI:10.1016/s0065-2776(08)60891-3

PMID:9100984

Abstract

摘要

相似文献

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.

Adv Immunol. 1997;64:283-350. doi: 10.1016/s0065-2776(08)60891-3.

Gammaglobulins, autoantibodies, therapeutic antibodies and anti-drug antibodies in rheumatoid arthritis.

Clin Exp Immunol. 2014 Dec;178 Suppl 1(Suppl 1):115-7. doi: 10.1111/cei.12534.

What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?

Int Arch Allergy Immunol. 1996 Dec;111(4):362-5. doi: 10.1159/000237393.

Anti-tumor necrosis factor-alpha monoclonal antibody therapy for rheumatoid arthritis.

Rheum Dis Clin North Am. 1998 Aug;24(3):593-614. doi: 10.1016/s0889-857x(05)70028-4.

[Anti-TNF-alpha monoclonal antibodies in the treatment of rheumatoid arthritis].

Rev Med Interne. 2000 Oct;21(10):854-62. doi: 10.1016/s0248-8663(00)00236-8.

[New treatments for rheumatoid arthritis].

Soins. 2004 Sep(688):37-8.

Rheumatoid arthritis and tumor necrosis factor alpha.

Autoimmunity. 2001;34(4):291-303. doi: 10.3109/08916930109014698.

Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis.

J Interferon Res. 1994 Oct;14(5):299-300. doi: 10.1089/jir.1994.14.299.

Arthritis Rheum. 1998 Mar;41(3):564-5. doi: 10.1002/1529-0131(199803)41:3<564::AID-ART27>3.0.CO;2-C.

Decrease in cell adhesion molecules by treatment with anti-tumor necrosis factor alpha monoclonal antibody.

Arthritis Rheum. 1997 Apr;40(4):789-90. doi: 10.1002/art.1780400433.

引用本文的文献

Treatment of rheumatoid arthritis with biological agents - as a typical and common immune-mediated inflammatory disease.

Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(8):600-608. doi: 10.2183/pjab.93.038.

Efficient T-cell priming and activation requires signaling through prostaglandin E2 (EP) receptors.

Immunol Cell Biol. 2016 Jan;94(1):39-51. doi: 10.1038/icb.2015.62. Epub 2015 Jun 8.

A multi-targeted approach to suppress tumor-promoting inflammation.

Semin Cancer Biol. 2015 Dec;35 Suppl:S151-S184. doi: 10.1016/j.semcancer.2015.03.006. Epub 2015 May 5.

Efficacy of anti-tumor necrosis factor therapy for extra-articular manifestations in patients with ankylosing spondylitis: a meta-analysis.

BMC Musculoskelet Disord. 2015 Feb 10;16(1):19. doi: 10.1186/s12891-015-0489-2.

Gentiolactone, a secoiridoid dilactone from Gentiana triflora, inhibits TNF-α, iNOS and Cox-2 mRNA expression and blocks NF-κB promoter activity in murine macrophages.

PLoS One. 2014 Nov 25;9(11):e113834. doi: 10.1371/journal.pone.0113834. eCollection 2014.

TNF inhibitor therapy for rheumatoid arthritis.

Biomed Rep. 2013 Mar;1(2):177-184. doi: 10.3892/br.2012.42. Epub 2012 Nov 29.

Optimizing infliximab therapy for inflammatory bowel disease- the tools are getting sharper.

Gastroenterol Hepatol (N Y). 2012 Feb;8(2):134-6.

Epstein-Barr Virus (EBV) Prevalence and the Risk of Reactivation in Patients with Inflammatory Arthritis Using Anti-TNF Agents and in those who are Biologic Naive.

Open Rheumatol J. 2009 Jul 13;3:30-4. doi: 10.2174/1874312900903010030.

Inhalation of carbon monoxide ameliorates collagen-induced arthritis in mice and regulates the articular expression of IL-1beta and MCP-1.

Inflammation. 2009 Apr;32(2):83-8. doi: 10.1007/s10753-009-9106-6.

An extensive phenotypic characterization of the hTNFalpha transgenic mice.

BMC Physiol. 2007 Dec 10;7:13. doi: 10.1186/1472-6793-7-13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献